Local News

Cornerstone BioPharma Licenses Drug

Posted November 10, 2006

— Cornerstone BioPharma

has licensed an antibiotic drug for treatment of infections of the lungs, throat and skin from a Japanese pharmaceutical firm.

Financial terms were not disclosed.

Cornerstone, which focuses on respiratory drugs, acquired the rights to Spectracef from Meiji Seika Kaisha. The deal covers licensing rights in the U.S.

Spectracef is an oral antibiotic. It targets pneumonia, bronchitis, tonsillitis and various skin infections.


Please with your WRAL.com account to comment on this story. You also will need a Facebook account to comment.

Oldest First
View all